Results 171 to 180 of about 113,930 (262)
Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatment. [PDF]
Verma S, Pradhan A, Thandi P.
europepmc +1 more source
Using a large Japanese real‐world database, we examined antidiabetic drug selection in first and second therapy stratified by renal function and study period. The earlier initiation of SGLT2 inhibitors and GLP‐1 receptor agonists increased over time, particularly in second therapy, with prescribing patterns increasingly aligned across renal function ...
Masashi Kubota +2 more
wiley +1 more source
Can the size of adrenal tumor impact hormonal secretion? A retrospective analysis of 170 adrenalectomies in a single center. [PDF]
Frey R +8 more
europepmc +1 more source
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu +4 more
wiley +1 more source
Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption. [PDF]
Laffin LJ, Nissen SE.
europepmc +1 more source
ABSTRACT Background Antipsychotic medications remain widely used in nursing homes (NHs) despite guidelines discouraging potentially inappropriate use. While home‐level variation is known, less is understood at the unit and organization levels, or across other psychotropic and non‐psychotropic drugs.
Darly Dash +9 more
wiley +1 more source
Hypoadrenocorticism‐like syndrome in a cat with Tritrichomonas foetus infection: a case report
A reduced sodium: potassium ratio is an uncommon finding in cats, and is typically associated with conditions such as hypoadrenocorticism, severe renal and cardiovascular diseases, cavitary effusion and certain non‐parasitic gastrointestinal diseases.
M. Crisonà +4 more
wiley +1 more source
Effect of renin-angiotensin-aldosterone system inhibitor and statin medication on periodontal status of patients at risk of cardiovascular disease: a systematic review and meta-analysis. [PDF]
Khalilurrahman ZA +6 more
europepmc +1 more source

